{"id":"https://genegraph.clinicalgenome.org/r/b38fd6d6-459c-425c-bc00-705a71c2b7f0v1.0","type":"EvidenceStrengthAssertion","dc:description":"Hereditary Paraganglioma-Pheochromocytoma Syndromes (PGL/PCC) [MONDO:0017366, PMID: 20301715] are associated with an increased risk of multiple paragangliomas and pheochromocytomas tumors within multiple organ systems transmitted in autosomal dominant inheritance. The molecular mechanism is loss of function in one of the 4 genes comprising the succinate dehydrogenase and SDHAF gene for flavination of SDHA, and stabilization of the SDH complex. This is a curation for SDHA and SDHA associated Hereditary Paraganglioma-Pheochromocytoma syndromes (PGL/PCC) with autosomal dominant inheritance (Paraganglioma 5, MIM: 614165). The autosomal recessive inherited Leigh syndrome (MIM: 256000), Cardiomyopathy, dilated, 1GG (MIM: 613642) and Mitochondrial Respiratory Chain Complex II deficiency (MIM: 252011) will be curated separately. SDHA encodes the flavoprotein subunit of the SDH-complex (succinate dehydrogenase). SDHA was first reported in relation to PGL/PCC in 1995 [Bourgeron et al., PMID: 7550341]. Germline loss-of-function mutations of SDHA gene have been described in only 3-7% of the patients with PGL/PCCs, in which most pathogenic variants are associated with very low disease penetrance, ranging from 0.1-4.9% [PMID: 29978154]. An initiation codon, two missense, four nonsense and two small deletion variants are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by experimental evidence. Absence of SDHA staining specifically associated with SDHA germline mutation in PGL/PCC tumors was demonstrated in 6 cases with 6 germline variants [PMID: 23282968]. Yeast models with null Sdh1 and Arg582Trp Sdh1 mutants showed loss of SDH1 due to instability of the mutant protein. SDHB protein, the catalytic component, is lost in the SDHA mutant patientâ€™s fresh adrenal paraganglioma tumor. WT yeast SDH1 can rescue the deficient growth of null Sdh1 mutant on minimal glycerol/ethanol but the yeast Arg582Trp Sdh1 mutant can not [PMID: 20484225]. In summary, the SDHA gene is definitely associated with autosomal dominant HPGL/PCC with low penetrance. This has been repeatedly demonstrated in both the genetic, and experimental, biochemical and functional studies, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b38fd6d6-459c-425c-bc00-705a71c2b7f0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2021-06-17T01:17:16.456Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2021-06-17T01:17:31.568Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3938ef48-7690-4f33-a2fa-004561919636","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/946093da-6658-4ae1-8aee-b9f24a523463","type":"Finding","dc:description":"No Sdh1 was detected in the SDH1 null mutant and the mutant transformed with the  Arg582Trp gene. Absence of Sdh1 in the cytosolic fraction of the four different strains. These results indicate that  the Arg582Trp mutation renders the protein more susceptible to proteolysis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20484225","rdfs:label":"Yeast model with Western analysis","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b4ee02ff-ff16-47fa-90c3-05e1b9e33736","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d4d518e-99b6-48ca-b2d0-49c79aa1ce43","type":"Finding","dc:description":"The SDH1 null mutant (aW303DSDH1) could not grow in minimal glycerol/ethanol medium, an integrated copy of SDH1 (aW303 deltaSDH1/ST20) can rescue the growth, but an integrated copy of the Arg582Trp mutant gene (aW303deltaSDH1/ST19) could.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20484225","rdfs:label":"Rescue in Yeast model with Spectrophotometry","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/923c8ddc-30ee-416a-acd1-83ae17a7a4b5","type":"EvidenceLine","dc:description":"6 Gastric GIST with 4 different germline variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e141b91c-a2b6-4278-a386-8207ff0e72eb","type":"Finding","dc:description":"Immunohistochemistry showed SDHA negative stain in all 6 gastric GIST with SDHA  germline mutations, 3 are truncating, 3 missense and 1 splice. All 6 had a 2nd hit in the SDHA locus: three LOH in the 5p15 region, two somatic mutations, and one 5p deletion.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23282968","rdfs:label":"Immunohistochemistry","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86125f66-6b34-4e4b-9fcc-583e23af5556_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Alterations at the canonical donor/acceptor sites (+/- 1, 2), typically lead to a loss of protein function (PMID: 16199547). It has been observed in individuals affected with head and neck paraganglioma and melanoma (PMID: 29177515, 26556299)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71d1b424-79a2-4381-8675-bc4f96ba4f98","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","rdfs:label":"Index 4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":44,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"extraadrenal, retroperitoneal","phenotypes":"obo:HP_0002668","previousTesting":true,"previousTestingDescription":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/86125f66-6b34-4e4b-9fcc-583e23af5556_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","allele":{"id":"https://genegraph.clinicalgenome.org/r/be1131bc-2dfa-40cc-822d-0293201a3526","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1432_1432+1del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10582429"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/214d5ed2-3ab1-4e90-a45d-1b40cc5bf5d2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"premature stop codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e190e31-ea41-4d75-b028-269ee8647dda","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","rdfs:label":"Index 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"extraadrenal, retroperitoneal","phenotypes":"obo:HP_0002668","previousTesting":true,"previousTestingDescription":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/214d5ed2-3ab1-4e90-a45d-1b40cc5bf5d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","allele":{"id":"https://genegraph.clinicalgenome.org/r/fff7fe9f-cfcf-4668-bd41-4463dc9cdccc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.223C>T (p.Arg75Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276119"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6aa0fe7d-5f32-4315-a846-2fdaf0ad589f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The most common pathogenic variant.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7260d6b-c816-4b88-a15e-c8af0d9d3c29","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","rdfs:label":"Index 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":15,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Adrenal unilateral","phenotypes":"obo:HP_0002666","previousTesting":true,"previousTestingDescription":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6aa0fe7d-5f32-4315-a846-2fdaf0ad589f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","allele":{"id":"https://genegraph.clinicalgenome.org/r/978bc721-98bd-4dee-8331-6b7055793c62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.91C>T (p.Arg31Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA168793"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5e41074d-f9e4-484c-9a37-a1f8e0dcbf97_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b2ac990-4750-41b2-80af-feeffee5f2e4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","rdfs:label":"Index 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":23,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Testicular sympathetic","phenotypes":"obo:HP_0002668","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5e41074d-f9e4-484c-9a37-a1f8e0dcbf97_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","allele":{"id":"https://genegraph.clinicalgenome.org/r/239de2f4-0753-471a-b9d0-49e76937ea2d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1534C>T (p.Arg512Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3173269"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f85568a3-bb3d-45cf-8e8d-a4bdba639d1d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75350dd3-a453-4f5a-8d11-b3137afcab6b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","rdfs:label":"Index 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":40,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Glomus carotid body","phenotypes":"obo:HP_0002668","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f85568a3-bb3d-45cf-8e8d-a4bdba639d1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","allele":{"id":"https://genegraph.clinicalgenome.org/r/467c3381-34cc-4120-8c41-133582bf906f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.985C>T (p.Arg329Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16611943"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ce57cdf7-35e4-4903-a68f-854a4417e23a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Absent or disrupted protein product.  Observed in individuals affected with clinical features of PGL/PCC (PMID: 28500238, 28546994, 23666964).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19a24da2-69bc-42b3-9ed9-242f4cfa2d30","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","rdfs:label":"Index 4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":48,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Head and Neck","phenotypes":"obo:HP_0002668","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ce57cdf7-35e4-4903-a68f-854a4417e23a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","allele":{"id":"https://genegraph.clinicalgenome.org/r/170b4919-3c78-4a62-b1f5-b22800cd85a7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1338del (p.His447MetfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/872808"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":9},{"id":"https://genegraph.clinicalgenome.org/r/4833b4b4-071c-4062-9007-8b0f6896a54e_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00d8b576-c596-46df-b00a-4f830e4cfe82_proband_score_evidence_line","type":"EvidenceLine","dc:description":"It changes initiator Methionine, reported in individuals with PCC/PGL, GIST [PMID: 10746566, 28384794, 31413764].Other variant(s) that disrupt this residue reported (PMID: 25488574, 15989954, 21858060, 26722403).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1515d68-fc01-44e0-be17-e604df954125","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","rdfs:label":"Index 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":66,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Extra-adrenal, thoracic","phenotypes":"obo:HP_0002668","previousTesting":true,"previousTestingDescription":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/00d8b576-c596-46df-b00a-4f830e4cfe82_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f27fd55-2d4f-4fcd-83f8-57a21f69755a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1A>C (p.Met1?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA119881"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4dcf6b0a-63ed-4d9d-ba34-6dfb9dab85a3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant has been observed in an individual affected with gastrointestinal stromal tumors (PMID: 23612575) and in individuals affected with paraganglioma-pheochromocytoma syndromes (PMID: 25720320, 28384794). Other variant(s) that disrupt this residue have been reported in cases (PMID: 20484225, 25405498, 22955521, 28546994).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe9abbdc-850b-42e8-8718-7f6eecf69601","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","rdfs:label":"Index 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":50,"detectionMethod":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Jugular PGL","phenotypes":"obo:HP_0002668","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4dcf6b0a-63ed-4d9d-ba34-6dfb9dab85a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29978154","allele":{"id":"https://genegraph.clinicalgenome.org/r/1aa3735c-2f6b-496e-a782-4dbf675757a5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1766G>A (p.Arg589Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3173350"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fef8b8a9-ad2e-4f2b-930f-4b8ebd83730c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant has been reported in  two other individuals (USA and Germany) in this cohort and individuals with SDHA-related conditions (PMID: 25595276, 28384794). Other variants in the same codon has also been reported in cases.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/101fe331-d2ed-497f-9586-0a91c4294b4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","rdfs:label":"Index 5","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":42,"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Vagal","phenotypes":"obo:HP_0002668","previousTesting":true,"previousTestingDescription":"Sanger sequencing and MLPA analyses (multiplex ligation-dependent probe amplification analyses) of  RET, WHL, SDHB, SDHC and SDHD genes","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fef8b8a9-ad2e-4f2b-930f-4b8ebd83730c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28384794","allele":{"id":"https://genegraph.clinicalgenome.org/r/440ca9cf-4a0a-4c24-b75f-ddc6c6120628","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004168.4(SDHA):c.1799G>A (p.Arg600Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3173431"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":2965,"specifiedBy":"GeneValidityCriteria8","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/HOeUDmk-ByA","type":"GeneValidityProposition","disease":"obo:MONDO_0017366","gene":"hgnc:10680","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_4833b4b4-071c-4062-9007-8b0f6896a54e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}